The global metastatic cancer therapy market is growing significantly with increasing sales of some major drugs like an Eli Lilly product Alimta with average sales of US$ 2.5 Billion per year; Prolia by Amgen having US$ 1.9 Billion sales in just 9 months of 2017; Products of Roche Avastin and Herceptin are the top selling drugs of this segment having sales of US$ 5.2 Billion & US$ 5.4 Billion respectively in the year 2017.

High medical needs of patients with metastatic cancers have fuelled global metastatic cancer therapy market at an impressive average 8 CAGR calculated on the basis of the market growth for each indication. Currently the global metastatic cancer therapy market is well flourished with more than 10 unique products including advance cancer therapies like targeted therapy, cancer vaccines, immunotherapies and some modern versions of chemotherapies like Jevtana.

Additionally, more than 60 products are currently in the later phases of clinical pipeline with almost 60% in phase-III and 37% in phase-I & II of the clinical trial.

"Global Metastatic Cancer Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024 Report Highlights:

• Drug Patent, Availability, Price & Dosage Analysis
• Market Analysis of Metastatic Cancer
• Management Approaches for Metastatic Cancer by Type
• Global Cancer Metastases Clinical Pipeline Overview: 66 Drugs
• Marketed Cancer Metastases Drugs Clinical Insight: 14 Drugs
• Future Perspective of Metastatic Cancer Market

Key Topics Covered:

1. Cancer Metastasis: New Perspectives of Old Problem

2. Metastatic Lung Cancer

3. Metastatic Bone Cancer

4. Metastatic Breast Cancer

5. Metastatic Liver Cancer

6. Metastatic Brain Cancer

7. Metastatic Prostate Cancer

8. Process of Metastasis in Other Different Types of Cancers

9. Patent, Availability, Price & Dosage Analysis of Metastatic Lung Cancer Therapeutics

10. Patent, Availability, Price & Dosage Analysis of Metastatic Bone Cancer Therapeutics

11. Patent, Availability, Price & Dosage Analysis of Metastatic Breast Cancer Therapeutics

12. Patent, Availability, Price & Dosage Analysis of Metastatic Liver Cancer Therapeutics

13. Patent, Availability, Price & Dosage Analysis of Metastatic Prostate Cancer Therapeutics

14. Market Analysis of Metastatic Cancer

15. Market Dynamics of Metastatic Cancer

16. Future Perspective of Metastatic Cancer Market

17. Global Cancer Metastases Clinical Pipeline Overview

18. Global Cancer Metastases Clinical Pipeline by Company, Indication & Phase

19. Marketed Cancer Metastases Drugs Clinical Insight

20. Competitive Landscape

• Allergan
• Amgen
• Biocompatibles International
• Boehringer Ingelheim Pharma
• Celsion Corporation
• DexTech Medical
• GlaxoSmithKline
• Hospira
• Immune Pharmaceuticals
• Insmed
• Novartis
• Pfizer
• Roche

Register as Visitor to CPhI China 2018!